As of 2025-09-16, the Fair Value of Ikena Oncology Inc (IKNA) is -5.10 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.43 USD, the upside of Ikena Oncology Inc is -456.71%.
With the market price of 1.43 USD and our fair value calculation, Ikena Oncology Inc (IKNA) is not a good investment. Investing in IKNA stocks now will result in a potential loss of 456.71%.
Note: valuation result may not be accurate due to the low predictability of business.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -44.26 | -34.12 | -68.77 | -68.17 | -49.23 | -52.91 |
| YoY growth | -163.14% | 22.91% | -101.55% | 0.88% | 27.77% | -42.63% |
| Market Cap (mil) | 170.97 |
| P/E | |
| Forward P/E |
| EPS | -1.02 |
| Avg earnings growth rate | -42.63% |
| TTM earnings |